Abstract:Vascular smooth muscle cells (VSMCs) play a role in the development of vascular disease, for example, neointimal formation, arterial aneurysm, and Marfan syndrome caused by genetic mutations in VSMCs, but little is known about the mechanisms of the disease process. Advances in induced pluripotent stem cell technology have now made it possible to derive VSMCs from several different somatic cells using a selection of protocols. As such, researchers have set out to delineate key signaling processes involved in triggering VSMC gene expression to grasp the extent of gene regulatory networks involved in phenotype commitment. This technology has also paved the way for investigations into diseases affecting VSMC behavior and function, which may be treatable once an identifiable culprit molecule or gene has been repaired. Moreover, induced pluripotent stem cell-derived VSMCs are also being considered for their use in tissue-engineered blood vessels as they may prove more beneficial than using autologous vessels. Finally, while several issues remains to be clarified before induced pluripotent stem cell-derived VSMCs can become used in regenerative medicine, they do offer both clinicians and researchers hope for both treating and understanding vascular disease. In this review, we aim to update the recent progress on VSMC generation from stem cells and the underlying molecular mechanisms of VSMC differentiation. We will also explore how the use of induced pluripotent stem cell-derived VSMCs has changed the game for regenerative medicine by offering new therapeutic avenues to clinicians, as well as providing researchers with a new platform for modeling of vascular disease.

Applications, challenges, and prospects of induced pluripotent stem cells for vascular disease

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future Challenges

Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives

Advances in the differentiation of pluripotent stem cells into vascular cells

Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy

Application Potential of Induced Pluripotent Stem Cells in Cell Therapy for Stroke

The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing

Endothelial dysfunction and cardiovascular diseases: The role of human induced pluripotent stem cells and tissue engineering

Potential Applications Of Induced Pluripotent Stem Cells For Cardiovascular Diseases

Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy

Applications of Induced Pluripotent Stem Cells (IPS) in the Study of Cardiovascular Disease

Induced pluripotent stem cells and cardiovascular disease

Differentiation And Application Of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery

The Challenges Of Stem Cell Therapy In Myocardial Infarction And Heart Failure And The Potential Strategies To Improve The Outcomes

Investigating Inherited Heart Diseases Using Human Induced Pluripotent Stem Cell-Based Models

Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies

Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies

Blood vessels in a dish: the evolution, challenges, and potential of vascularized tissues and organoids